Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand

被引：6

作者：

Shahait, Mohammed ^{[1
]}

Mukherji, Deborah ^{[2
]}

El-Hout, Yaser ^{[1
]}

机构：

[1] Amer Univ Beirut, Div Urol & Kidney Transplantat, Beirut, Lebanon

[2] Amer Univ Beirut, Div Oncol, Beirut, Lebanon

来源：

INDIAN JOURNAL OF UROLOGY | 2015年 / 31卷 / 02期

关键词：

Metastatic; partial nephrectomy; renal cell carcinoma;

D O I：

10.4103/0970-1591.154300

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Nephron-sparing surgery (NSS) for renal cell carcinoma (RCC) offers comparable oncologic results, but a lower risk of chronic kidney disease, when compared with radical nephrectomy. However, there are limited data in the literature examining the safety of NSS in the setting of metastatic RCC. To evaluate the feasibility of NSS and impact on cancer-specific survival (CSS) in patients with metastatic disease, we performed a systematic review of the literature. There is ample evidence that NSS is feasible in metastatic RCC, with comparable results in terms of CSS compared with radical cytoreductive nephrectomy.

引用

页码：102 / 105

页数：4

共 28 条

[1]

BAZEED MA, 1986, EUR UROL, V12, P238

[2] Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm [J].

Becker, F ;

Siemer, S ;

Hack, M ;

Humke, U ;

Ziegler, M ;

Stöckle, M .

EUROPEAN UROLOGY, 2006, 49 (06) :1058-1064

[3] Cytoreductive Partial Nephrectomy Does Not Undermine Cancer Control in Metastatic Renal Cell Carcinoma: A Population-Based Study [J].

Capitanio, Umberto ;

Zini, Laurent ;

Perrotte, Paul ;

Shariat, Shahrokh F. ;

Jeldres, Claudio ;

Arjane, Philippe ;

Pharand, Daniel ;

Widmer, Hugues ;

Peloquin, Francois ;

Montorsi, Francesco ;

Patard, Jean-Jacques ;

Karakiewicz, Pierre I. .

UROLOGY, 2008, 72 (05) :1090-1095

[4] Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer [J].

Flanigan, RC ;

Salmon, SE ;

Blumenstein, BA ;

Bearman, SI ;

Roy, V ;

McGrath, PC ;

Caton, JR ;

Munshi, N ;

Crawford, ED .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1655-1659

[5] Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma? [J].

Hellenthal, Nicholas J. ;

Mansour, Ahmed M. ;

Hayn, Matthew H. ;

Schwaab, Thomas .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (01) :36-41

[6]

Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8

[7] Partial Nephrectomy Versus Radical Nephrectomy in Patients With Small Renal Tumors-Is There a Difference in Mortality and Cardiovascular Outcomes? [J].

Huang, William C. ;

Elkin, Elena B. ;

Levey, Andrew S. ;

Jang, Thomas L. ;

Russo, Paul .

JOURNAL OF UROLOGY, 2009, 181 (01) :55-61

[8] Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma [J].

Hutterer, Georg C. ;

Patard, Jean-Jacques ;

Colombel, Marc ;

Belldegrun, Arie S. ;

Pfister, Christian ;

Guille, Francois ;

Artibani, Walter ;

Montorsi, Francesco ;

Pantuck, Allan J. ;

Karakiewicz, Pierre I. .

CANCER, 2007, 110 (11) :2428-2433

[9] Increased Risk of Overall and Cardiovascular Mortality After Radical Nephrectomy for Renal Cell Carcinoma 2 cm or Less [J].

Kates, Max ;

Badalato, Gina M. ;

Pitman, Max ;

McKiernan, James M. .

JOURNAL OF UROLOGY, 2011, 186 (04) :1247-1253

[10] Clinical Results and Pharmacokinetics of Sorafenib in Chronic Hemodialysis Patients with Metastatic Renal Cell Carcinoma in a Single Center [J].

Kennoki, Takafumi ;

Kondo, Tsunenori ;

Kimata, Naoki ;

Murakami, Jun ;

Ishimori, Isamu ;

Nakazawa, Hayakazu ;

Hashimoto, Yasunobu ;

Kobayashi, Hirohito ;

Iizuka, Junpei ;

Takagi, Toshio ;

Yoshida, Kazuhiko ;

Tanabe, Kazunari .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (05) :647-655

← 1 2 3 →